Aurora Cannabis (TSE:ACB) Stock Gets Downgrade from TD

Key Points

• TD downgraded Aurora Cannabis from “buy” to “sell” and lowered its price target from C$8.00 to C$7.80, which still implies 7.14% upside from the prior close.
• Analyst views are mixed: MarketBeat reports a consensus “hold” rating and C$6.60 price target, with one buy, one hold, and one sell rating.
• Aurora reported quarterly revenue of C$67.55 million and a loss of C$0.07 per share; its shares rose 1% to C$7.28 in Wednesday trading.

Aurora Cannabis (TSE:ACB - Get Free Report) was downgraded by TD from a "buy" rating to a "sell" rating in a research note issued to investors on Wednesday, BayStreet reports. They currently have a C$7.80 price objective on the stock, down from their prior price objective of C$8.00. TD's target price points to a potential upside of 7.14% from the stock's previous close.

Several other research firms have also weighed in on ACB. BMO Capital Markets raised Aurora Cannabis to a "hold" rating in a research note on Wednesday, August 5th. ATB Cormark Capital Markets increased their target price on shares of Aurora Cannabis from C$5.60 to C$7.00 and gave the stock a "tender" rating in a research report on Tuesday, October 6th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Aurora Cannabis presently has a consensus rating of "Hold" and a consensus price target of C$6.60.

Aurora Cannabis Trading Up 1.0%

Shares of ACB traded up C$0.07 during mid-day trading on Wednesday, hitting C$7.28. The company had a trading volume of 969,759 shares, compared to its average volume of 414,833. Aurora Cannabis has a 1-year low of C$3.59 and a 1-year high of C$8.75. The business's 50-day simple moving average is C$5.72 and its 200-day simple moving average is C$4.94. The stock has a market cap of C$451.05 million, a PE ratio of -3.75 and a beta of 0.64. The company has a quick ratio of 2.48, a current ratio of 5.36 and a debt-to-equity ratio of 4.30.

Aurora Cannabis (TSE:ACB - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported C($0.07) EPS for the quarter. The company had revenue of C$67.55 million for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%. Sell-side analysts forecast that Aurora Cannabis will post -0.22 earnings per share for the current year.

About Aurora Cannabis

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty's ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.